Relevant research has demonstrated that the inflammatory cytokines IL6/IL6R amplify the signaling of the Notch-Jagged pathway, which stimulates the generation of hybrid epithelial-mesenchymal cancer stem cells, and that inhibition of CD46 gene expression reduces the effects of proliferation, invasion, and migration capacity of breast cancer cells. Here, IL6 is linked to breast cancer.